Navigation Links
Ranir, LLC Announces the Acquisition of Placontrol, Inc.
Date:1/12/2009

GRAND RAPIDS, Mich., Jan. 12 /PRNewswire/ -- Ranir, LLC, a leading consumer products oral care company, announced today that it has acquired Placontrol, Inc., a foremost manufacturer and marketer of interdental oral care products under the Plackers(R) trademark. Headquartered in San Diego, California, Placontrol is the founder of the convenience dental flosser. Terms of the transaction were not disclosed.

Ranir, headquartered in Grand Rapids, Michigan manufactures and markets consumer oral care products to leading retail customers and branded oral care companies in North America. Led by CEO Christine Henisee, Ranir has expanded its sales platform to include serving virtually all top chain drug stores, mass merchandisers, supermarkets, and discount retailers in North America along with some key global branded oral care companies. Ranir has an extensive line of consumer oral care products, including tooth-whitening wraps, whitening trays, dissolving whitening strips, manual and power toothbrushes, dental floss and flossers, travel kits, night protectors, and other oral care accessories.

"Teaming with Placontrol will accelerate our growth through enhanced new product development capabilities as well as increased supply chain efficiencies," said Henisee, who joined Ranir in 2003 and has more than 30 years of consumer products experience. "Placontrol is an innovation leader in the flosser category with a significant pipeline in oral care."

Placontrol's products are unique, patent-protected interdental and gum care products that have significant potential for growth. Plackers Dental Flossers and Interdental brushes are distributed in most major U.S. retail chains such as Walmart, CVS, Walgreens, Rite Aid, Dollar Tree and Kroger, in leading European retailers such as Tesco and Boots, and in 30 other countries worldwide. Ingram Chodorow, the founder of Placontrol, said, "Placontrol brings an extensive patent portfolio and a highly productive research and development capability which Ranir expects will enrich both companies with new technology for many years to come."

Ms. Henisee added, "Ranir and Placontrol combine innovative, high-quality products with excellent customer service to meet the demands of leading retailers and their consumers. Furthermore, we expect continued growth fueled by the increased emphasis on both preventive and cosmetic dental care, favorable demographics and the growing awareness of the connection between oral health and overall wellness. Ranir and Placontrol compete in a high profile market with an innovation orientation."

Current management, including Chief Executive Officer Christine Henisee and Chief Financial Officer Joe Townshend, will continue to lead Ranir. Ingram Chodorow will be joining the Ranir Board of Directors, with both Devin Chodorow and Brett Chodorow joining the Ranir management team.


'/>"/>
SOURCE Ranir, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Varian Medical Systems Announces Net Orders Growth Estimates for the First Quarter of Fiscal Year 2009
2. Mindray Announces Preliminary 2008 Operating Results
3. BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections
4. Alsius Corporation Pre-Announces Record Fourth Quarter and Full Year 2008 Revenue
5. Allen Technologies, Inc. Announces Vigo Interactive Communication and Education System Agreement with Saint John's Health Center, Santa Monica, California
6. Rubicon Genomics Announces a Licensing Agreement With Abbott to Develop and Commercialize DNA Methylation Cancer Tests
7. Oleen Pinnacle Announces Acquisition of Partners in Health Systems
8. Thermage, Inc. Announces Name Change to Solta Medical, Inc.
9. Miami Beach Real Estate Attorney Announces Specialized Legal and Realty Services for Clients Buying Bank-Owned Luxury Miami Beach Condos
10. Genomma Lab Announces Initiation of Stock Repurchase Fund
11. Kensey Nash Corporation Announces Its Second Quarter 2009 Earnings Release Date and Teleconference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2016)... ... 2016 , ... Research has shown that building shame resilience ... and level of relapse. , At the 2016 iaedp Symposium, the ... the critical tasks of the recovery phase and beyond including relapse prevention and ...
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the ... a variety of colors, assortments and packaging. This staple for Valentine’s Day is a ... location. , For Valentine’s Day, not only are long-stem roses available, but also ...
(Date:2/5/2016)... City, UT (PRWEB) , ... February 05, 2016 , ... ... Whole-Food Nutrition , announced that the much-anticipated feature with author Jahnavi Foster, specialist in ... Humans Amateur TV Network. , Each week, on his weekly Whole-Food Warrior TV show, ...
(Date:2/5/2016)... ... February 05, 2016 , ... The event is being held ... Event Center in Minneapolis, Minn. Triumph Over Parkinson’s will fund nearly $100,000 for research ... Schneiderman’s Furniture, lives with Parkinson’s disease and is the architect of this informative event ...
(Date:2/5/2016)... Santa Rosa, CA (PRWEB) , ... February 05, ... ... are pleased to announce the addition of micro-needling services in their Napa Valley ... appearance. The founders of Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... 2016 Wegener Polyangiitis - Pipeline Review, ... ,Wegener Polyangiitis - Pipeline Review, H2 2015, provides ... This report provides comprehensive information on the ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ...
(Date:2/4/2016)... -- Omnicell, Inc. (NASDAQ: OMCL ), a leading provider of ... announced results for its fiscal year and fourth quarter ... --> GAAP results: Revenue for the fourth quarter ... 4.1% from the third quarter of 2015, and up ... 2014. Revenue for the year ended December 31, 2015 was ...
(Date:2/4/2016)... 2016  Blueprint Medicines Corporation (NASDAQ: BPMC ... selective investigational kinase medicines for patients with genomically ... board of directors of Lonnel Coats , ... of industry-related experience. Jeffrey Albers ... strong strategic experience developing and commercializing numerous oncology ...
Breaking Medicine Technology: